Worldwide Antibacterial Coatings increase by 9.8% over 20 years

According to a recent report from GVR (Grand View Research Inc), a leading U.S.-based research firm, the global antibacterial coatings market is projected to reach $45.023 million by 2020. This growth is expected to be driven primarily by rising demand for medical device coatings and increasing awareness around indoor air quality, especially in North America.

Over the next six years, the demand for antimicrobial coatings in the medical field is set to play a major role in expanding the market. Additionally, the growing popularity of air quality products has encouraged more investment in the development of antibacterial paints and surface treatments. These trends are shaping the future of the industry and creating new opportunities for innovation.

However, the industry also faces challenges. From 2014 to 2020, stricter regulations and greater emphasis on health and environmental safety have made it harder for companies to enter the market. Fluctuating raw material prices, particularly for silver-based components, have also created uncertainty and affected production costs.

In 2013, the global antibacterial coating market reached 310.3 thousand tons, and it's expected to nearly double by 2020, with a compound annual growth rate of 9.8%. Surface-modified coatings remain a dominant segment, accounting for 53.9% of total volume in 2013 and likely to maintain their strong position in the coming years.

The powder coating segment is also gaining momentum, with revenue expected to hit $22.132 million by 2020, growing at a faster pace of 13.2% annually. Meanwhile, indoor air quality applications continue to be one of the largest drivers, making up 26.9% of the total volume in 2013.

Medical facilities are another key application area, with the market for antibacterial coatings in this sector expected to grow steadily, reaching 151.6 thousand tons by 2020 at a 10.2% CAGR. North America, which accounted for 39% of the global market in 2013, is anticipated to grow at a 10.6% CAGR through 2020. Europe is also expected to see steady expansion, with market value reaching $10.439 million by 2020.

The top four players in the market—AkzoNobel, Sherwin-Williams, Dow Microbiological Control, and Diamond Vogel—held 40% of the market share in 2013. As competition intensifies, these companies are likely to invest more in R&D and strategic partnerships to maintain their positions in the evolving landscape.